Latest from Oxehealth
Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision
RNS Investor Release
We at Oxehealth are delighted to announce that we've been selected as one of the “First 100 Digital Health Companies” by Healthcare UK. The list was announced by Healthcare UK this morning.
Oxehealth was featured in the top 19 UK healthcare companies by Beauhurst, who specialize in researching and analyzing the UK’s fastest growing companies.
An Oxford-based company which can turn video cameras into health monitors is set to raise £5m in fresh cash, as it sees demand surge among care homes and mental health trusts.
Oxehealth have signed a number of contracts in Q1 2020, signalling a promising year with significant growth opportunities ahead.
The British Standards Institute (BSI) has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.